Evaluation of the relationship between endocrine organ masses; the thyroid and breasts

Aim: The aim of this study is to investigate the co-occurrence of thyroid masses (TM) and breast masses (BM) and to examine related demographic features. Materials and Methods: The study included female patients; who were followed up in the general surgery outpatient clinic in the years between 2015 and 2020 because of thyroid nodules and underwent breast ultrasonography concurrently. Participants were divided into two groups as group-1 with the co-occurrence of thyroid and breast masses and group-2 with a TM but having no BM. The two groups were compared for age, body mass index (BMi), the number of children, the length of breastfeeding, TM size, TSH levels, vitamin D levels, and smoking status. Results: The study included 267 patients with thyroid nodules. Of the patients; 70.03% had comorbid BM but 29.96% had no BM. No statistically significant differences were found in age, smoking status, BMi, TSH levels, vitamin D levels, and thyroid nodule size between the two groups (p > 0.05). The number of births was fewer and the duration of breastfeeding was shorter in the group of patients having BM concomitantly (p < 0.001). There was not a correlation between the size of TM and the size of BM (p: 0.839, r: 0.012). Conclusion: in our study, it was found that most of the patients with thyroid nodules also had a mass in their breasts and this finding was associated with the duration of breastfeeding, the number of births, and the vitamin D level.

PDF

___

1. Papini E, Guglielmi R, Bianchini A, et al. Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features. J Clin Endocrinol Metab 2002;87(5):1941–6.
2. Tunbridge WMG, Evered DC, Hall R, et al. The Spectrum of Thyroid Disease in a Community: The Whickham Survey. Clin Endocrinol (Oxf) 1977;7(6):481–93.
3. isik A, Firat D, Yilmaz i, et al. A survey of current approaches to thyroid nodules and thyroid operations. int J Surg. 2018;54:100- 4.
4. Dean DS, Gharib H. Epidemiology of thyroid nodules. Vol. 22, Best Practice and Research: Clinical Endocrinology and Metabolism 2008: 901–11.
5. Yildirim Simsir i, Cetinkalp S, Kabalak T. Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma. Med Princ Pract 2020; 29(1):1–5.
6. Guray M, Sahin AA. Benign Breast Diseases: Classification, Diagnosis, and Management. Oncologist 2006;11(5):435–49.
7. isik A, Soran A, Grasi A, Barry N, Sezgin E. Lymphedema after Sentinel Lymph Node Biopsy: Who is at Risk? Lymphat Res Biol. 2021;10.
8. Palli D, Turco MR Del, Simoncini R, et al. Benign breast disease and breast cancer: A case-control study in a cohort in italy. int J Cancer 1991; 47(5): 703–6.
9. Sindoni A, Fama F, Rosano A, et al. Thyroid nodules coexisting with either cystic or solid breast nodules: A new clue for this association between nodules coming from ultrasonography. Gland Surg 2017; 6(6):630–7.
10. Adamopoulos DA, Kapolla N, Michalakis A, et al. Thyroid disease in patients with benign and malignant mastopathy. Cancer. 1986;57(1):125–8.
11. Bolf EL, Sprague BL, Carr FE. A Linkage Between Thyroid and Breast Cancer: A Common Etiology? Cancer Epidemiol Biomarkers Prev 2019; 28(4):643–9.
12. Li H, Wang Z, Liu J-S, et al. Association Between Breast and Thyroid Lesions: A Cross-Sectional Study Based on Ultrasonography Screening in China. Thyroid 2020; 30(8): 1150–8.
13. Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley CS. incidence of breast carcinoma in women with thyroid carcinoma. Cancer 1999; 85(3):696–705.
14. Muller i, Pinchera A, Fiore E, et al. High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol invest. 2011;34(5):349-52.
15. Nielsen SM, White MG, Hong S, et al. The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis. AACR 2016; 25(2): 231–8.
16. Silva JM, Domínguez G, Gonzílez-Sancho JM, et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 2002; 21(27): 4307–16.
17. Hall LC, Salazar EP, Kane SR, et al. Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 2008; 109(1–2):57–66.
18. Yane K, Kitahori Y, Konishi N, et al. Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett 1994; 84(1): 59–66.
19. Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010; 20(1): 33–41.
20. Shinde SS, Forman MR, Kuerer HM, et al. Higher parity and shorter breastfeeding duration. Cancer 2010;116(21):4933–43.
21. Pham TM, Fujino Y, Mikami H, et al. Reproductive and menstrual factors and thyroid cancer among Japanese women: The Japan collaborative cohort study. J Women’s Heal 2009 ;18(3):331–5.
22. Mayberry RM, Stoddard-wright C. Breast cancer risk factors among black women and white women: Similarities and differences. Am J Epidemiol 1992;136(12):1445–56.
23. Kim SW, Lee JH, Shon HS, et al. Association of breastfeeding with thyroid function and autoimmunity in postmenopausal women. Endocrine 2021; 71(1):130–8.
24. Xhaard C, Rubino C, Cléro E, et al. Menstrual and Reproductive Factors in the Risk of Differentiated Thyroid Carcinoma in Young Women in France: A Population-Based Case-Control Study. Am J Epidemiol 2014; 180(10):1007–17.
25. Schnitt, Stuart J. Pathology of benign breast disorders. Breast diseases 2000:90.
26. Boeke CE, Tamimi RM, Berkey CS, et al. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control 2015; 26(8): 1181–7.
27. Goldner W, Laney N, Meza J, et al. The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. int J Endocrinol 2010:2010.
28. Feldman D, Krishnan A V, Swami S, et al. The role of vitamin D in reducing cancer risk and progression. Nature Reviews Cancer 2014; 14: 342–57.